Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies. (Q46030933)
scientific article published in May 2009
Language:
(P31) (Q13442814)
(P304) 1232-1241
(P433) 5
(P478) 60
(P577) Friday, May 1, 2009
(P921) (Q269829)
(Q187255)
(Q725307)
(P1433) (Q4797636)
(P1476) "Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies." (language: en)
(P2093) Nemanja Damjanov
Robert S Kauffman
George T Spencer-Green
(P2860) (Q52221782)
(Q46019776)
other details
description scientific article published in May 2009

External Links